ULTIVAIR 50/110MG CAP

ULTIVAIR 50/110MG CAP is a combination inhalation capsule containing glycopyrronium and indacaterol. This dual-action bronchodilator is designed for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adults. Glycopyrronium works as a long-acting muscarinic antagonist, while indacaterol functions as a long-acting beta-2 agonist, together helping to improve airflow and reduce symptoms like shortness of breath and wheezing. Suitable for once-daily dosing, ULTIVAIR helps patients maintain better respiratory function and exercise tolerance throughout the day.